You are here: Industry Insights > Diagnosis

News List

RCGP calls for better access to cancer diagnostic tests pharmatimes
November 29, 2018
GP access to appropriate diagnostic tests in the community is currently amongst the lowest in Europe, a report by The Health Foundation has found.
Gov’t unveils intent to improve cancer diagnosis pharmatimes
October 11, 2018
The government has announced plans to improve the diagnosis of cancer, with the aim of detecting three out of four cases at an early stage by 2028.
New AI tool accurately identifies lung cancer type biospectrum
September 20, 2018
A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth, a new study shows.
PHE data shows link between cancer diagnosis route and treatment pharmatimes
August 17, 2018
Public Health England (PHE) has revealed new data showing that the way that cancer patients are diagnosed can affect their treatment options.
Pill for breast cancer diagnosis may outperform mammograms europeanpharmaceuticalreview
May 03, 2018
Researchers are developing a pill that makes tumours light up when exposed to infrared light…
NUS researchers develop chip for faster diagnosis biospectrumasia
April 02, 2018
Detection can be performed using standard laboratory microscopes, making this approach highly attractive for use in point-of-care diagnostics.
Singapore's Restalyst develops new method to improve liver cancer diagnosis prnasia
November 09, 2017
Singapore biomedical firm Restalyst has developed a new algorithm to detect liver cancer more accurately, improving the sensitivity to 90%.
Trial to identify breath biomarkers to improve the early detection and diagnosis of cancer cphi-online
July 13, 2017
Owlstone Medical and Cancer Research UK initiate pan cancer clinical trial.
New technology could dramatically shorten diagnosis time of stroke patients europeanpharmaceuticalreview
May 12, 2017
An ambitious collaboration between Brainomix, an emerging British business, and Boehringer Ingelheim, one of the world’s largest drug companies, is poised to expedite and improve treatment of stroke, the second biggest killer disease in Europe.
RGC, UK Biobank and GSK launch new initiative to improve disease diagnosis pharmaceutical-technology
March 27, 2017
Regeneron Genetics Center (RGC), UK Biobank and GSK have launched a gene sequencing initiative on the world's detailed health database.

Previous page 1 2 Next page